Report: Clemson not expanding PED testing following title-game suspensions for positive ostarine tests
Even though the Clemson Tigers won the College Football Playoff title in convincing fashion, the team was hampered in the buildup to the game because of a positive PED test for star DL Dexter Lawrence.
Lawrence and three other Tigers were suspended for the game, with positive tests for ostarine being the culprit.
However, according to a report from PostAndCourier.com, Clemson isn’t expanding its drug testing for football players:
Clemson did not test — and has no plans to test — more members of its newly crowned national championship football team for performance enhancing drugs as part of an in-house probe in the wake of three ostarine suspensions last month. Failed drug tests kept star defensive tackle Dexter Lawrence and two other players out of College Football Playoff wins over Notre Dame and Alabama.
Fewer than 20 Clemson players were tested in a random and routine NCAA drug screening of championship event participants. That is, more than 15 percent of those Tigers screened tested positive for performance enhancing drugs (PEDs).
The NCAA is the agency responsible for drug testing as of now, so Clemson is likely under no obligation to expand its in-house testing.
It is possible, though, that the NCAA will keep a closer eye on the Tigers moving forward after the positive tests this postseason.